Details
-
Change Request
-
Resolution: Persuasive
-
Highest
-
At-Home In-Vitro Test Report (FHIR)
-
1.0.0-ballot
-
Orders & Observations
-
Device - At-Home In-Vitro Test
-
-
Sarah Gaunt / Riki Merrick : 6 - 0 - 3
-
Correction
-
Compatible, substantive
Description
Why is owner and manufacturer both must support? What is the use case where they will be different?
Suggest only making the Manufacturer a must support. Or if both have a rationale, add in a comment.
Attachments
Issue Links
- is voted on by
-
BALLOT-39514 Affirmative - Mitra Rocca : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40684 Affirmative - Elaine Johanson : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40692 Affirmative - John Hassenplug : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40700 Affirmative - Konstantinos Makrodimitris : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40708 Affirmative - Jose Galvez : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40716 Affirmative - Norman Gregory : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40724 Affirmative - Edward Bearden : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40732 Affirmative - Amy Malla : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40740 Affirmative - Marti Velezis : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40748 Affirmative - William Hess : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40756 Affirmative - Ronald Claros : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted
-
BALLOT-40764 Affirmative - Virginia Hussong : 2022-Sep-FHIR IG HOME IV REPORT R1 STU
- Balloted